These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26463149)

  • 21. Diffusion Weighted Magnetic Resonance Imaging for the Classification of Focal Liver Lesions as Benign or Malignant.
    Caraiani C; Chiorean L; Fenesan DI; Lebovici A; Feier D; Gersak M; Calin AM; Dan M; Militaru C; Mare C; Ciobanu L; Badea R
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):309-17. PubMed ID: 26405703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions.
    Kono R; Fujimoto K; Terasaki H; Müller NL; Kato S; Sadohara J; Hayabuchi N; Takamori S
    AJR Am J Roentgenol; 2007 Jan; 188(1):26-36. PubMed ID: 17179342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.
    Vossen JA; Buijs M; Liapi E; Eng J; Bluemke DA; Kamel IR
    J Comput Assist Tomogr; 2008; 32(5):750-6. PubMed ID: 18830105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
    Vogl TJ; Hammerstingl R; Keck H; Felix R
    Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dynamic enhanced CT evaluation of solitary pulmonary nodules].
    Ye XD; Yuan Z; Ye JD; Li HM; Xiao XS
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):308-12. PubMed ID: 21575507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI?
    Satoh S; Kitazume Y; Ohdama S; Kimula Y; Taura S; Endo Y
    AJR Am J Roentgenol; 2008 Aug; 191(2):464-70. PubMed ID: 18647918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solitary necrotic nodules of the liver mimicking hepatic metastasis: report of two cases.
    Yoon KH; Yun KJ; Lee JM; Kim CG
    Korean J Radiol; 2000; 1(3):165-8. PubMed ID: 11752949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing focal hepatic lesions by free-breathing intravoxel incoherent motion MRI at 3.0 T.
    Watanabe H; Kanematsu M; Goshima S; Kajita K; Kawada H; Noda Y; Tatahashi Y; Kawai N; Kondo H; Moriyama N
    Acta Radiol; 2014 Dec; 55(10):1166-73. PubMed ID: 24316660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can Spectral CT Imaging Improve the Differentiation between Malignant and Benign Solitary Pulmonary Nodules?
    Zhang Y; Cheng J; Hua X; Yu M; Xu C; Zhang F; Xu J; Wu H
    PLoS One; 2016; 11(2):e0147537. PubMed ID: 26840459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging.
    Heilmaier C; Lutz AM; Bolog N; Weishaupt D; Seifert B; Willmann JK
    Radiology; 2009 Dec; 253(3):724-33. PubMed ID: 19789232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Challenging Case of Solitary Necrotic Nodules of the Liver Mimicking Hepatic Metastases: CT, MRI, and PET-CT Findings.
    Hwang JY; Lee JE; Jung MJ
    J Belg Soc Radiol; 2020 Apr; 104(1):16. PubMed ID: 32292875
    [No Abstract]   [Full Text] [Related]  

  • 35. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.
    Hwang J; Kim YK; Jeong WK; Choi D; Rhim H; Lee WJ
    Radiology; 2015 Jul; 276(1):137-46. PubMed ID: 25734551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnosis of hypovascular hepatic lesions showing hypo-intensity in the hepatobiliary phase of Gd-EOB- DTPA-enhanced MR imaging in high-risk patients for hepatocellular carcinoma.
    Nakamura S; Nouso K; Kobayashi Y; Shiraha H; Ohnishi H; Toshimori J; Kuwaki K; Hagihara H; Takayama H; Yamamoto K
    Acta Med Okayama; 2013; 67(4):239-44. PubMed ID: 23970322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR imaging of primary hepatic neuroendocrine neoplasm and metastatic hepatic neuroendocrine neoplasm: a comparative study.
    Sheng R; Xie Y; Zeng M; Ji Y; Rao S; Chen C
    Radiol Med; 2015 Nov; 120(11):1012-20. PubMed ID: 25907993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.